Revenio is a globally successful Finnish health technology company. As the leading global manufacturer in ophthalmic devices, Revenio Group Oyj provides innovative solutions for eye diagnostics. Their iCare brand specializes in devices for measuring intraocular pressure, imaging the fundus of the eye, and conducting perimetry tests.

These tools play a crucial role in the identification, diagnosis, and monitoring of glaucoma. Revenio's commitment to quality and responsibility is evident in their sustainable business practices and their focus on reducing their net impact. For investors seeking a promising opportunity, Revenio proves to be an excellent investment target, supported by their positive financial figures, growth prospects, and a comprehensive investor relations program.

Stay updated with Revenio's performance through their reports, presentations, and videos, and mark your calendars for the upcoming Q3 2023 interim report on October 26th. Trust Revenio Group Oyj to deliver cutting-edge advancements in eye care technology